Dan Cerqueira Co‑Chairs Session at IBA’s 10th Annual Corporate Governance Conference
December 03, 2025
On December 3, 2025, Cravath partner Daniel J. Cerqueira participated in the International Bar Association’s 10th Annual Corporate Governance Conference, which was held December 3‑4 in Frankfurt, Germany. Dan co‑chaired a session entitled “Shareholder Rights and Activism: What Were the Highlights of 2025 and What to Expect for 2026,” which included a review of the most notable activist campaigns from 2025, highlighting their impact on corporate strategies and shareholder value, regulatory developments which have the potential to influence the direction of activist campaigns and the trend of global activist campaigns including the increased role of U.S. activist investors in European markets.
Related Practices & Industries
Speakers
- Photo
-
-
J.D., 2013, Harvard Law Schoolmagna cum laude
-
B.A., 2010, Cornell UniversityPhi Beta Kappa
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
October 20, 2025
Banco Sabadell’s Defense Against BBVA’s Takeover Bid
On October 17, 2025, Banco Sabadell announced that the public takeover bid launched by BBVA in May 2024 received support from only 25.47% of shareholders, and therefore lapsed as it failed to reach the minimum acceptance threshold required for completion. Banco Sabadell will continue as an independent bank. Cravath is representing Banco Sabadell as U.S. counsel in connection with this matter.
Deals & Cases
October 02, 2025
Occidental’s $9.7 Billion Sale of OxyChem to Berkshire Hathaway
On October 2, 2025, Occidental, an international energy company, and Berkshire Hathaway announced a definitive agreement for Berkshire Hathaway to acquire Occidental’s chemical business, OxyChem, in an all‑cash transaction for $9.7 billion, subject to customary purchase price adjustments. Cravath is representing Occidental in connection with the transaction.
Deals & Cases
September 22, 2025
Premier’s $2.6 Billion Acquisition by Patient Square
On September 22, 2025, Premier, Inc. (“Premier”), a leading technology‑driven health care improvement company, announced that it has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital (“Patient Square”) in a transaction valued at $2.6 billion. Under the terms of the agreement, which has been unanimously approved by Premier’s Board of Directors, Premier stockholders will receive $28.25 in cash per share. Cravath is representing the Transaction Committee of Premier’s Board of Directors in connection with the transaction.
Deals & Cases
August 07, 2025
Paramount Global Completes Merger with Skydance
On August 7, 2025, Paramount Global and Skydance Media (“Skydance”) announced the completion of their merger, creating a standalone global media and entertainment company, Paramount, a Skydance Corporation (“Paramount”). Paramount Class B shares will begin trading today on the Nasdaq Stock Market LLC under “PSKY.” Cravath represented the Paramount Special Committee in connection with the transaction.
